In recent years many advances have been made in the fight against HIV-1 infection. However, the lack of a vaccine, together with the increasing resistance to the highly active anti-retroviral therapy (HAART), make HIV-1 infection still a serious global emergency. Thus, new compounds with original modes of action are continuously required, and natural products have ever been a very interesting class of pharmacologically active molecules. Some of them have been used since ancient times against viral infections. Here we present a work in which we suggest that kuwanon-L, a natural product active as an HIV-1 integrase (IN) inhibitor, might exert its overall antiviral activity through binding to multiple viral targets. Specific enzymatic tests, together with a time-of-addition (TOA) experiment, support our hypothesis of binding both to IN and to reverse transcriptase (RT). Overall, this compound can be considered an attractive lead for the development of new classes of antiviral agents able to overcome the problem of resistance, due to its ability to exert its action by binding simultaneously to multiple viral targets.

Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding / Martini, R.; Esposito, F.; Corona, A.; Ferrarese, R.; Ceresola, E. R.; Visconti, L.; Tintori, C.; Barbieri, A.; Calcaterra, A.; Iovine, V.; Canducci, F.; Tramontano, E.; Botta, M.. - In: CHEMBIOCHEM. - ISSN 1439-4227. - 18:4(2017), pp. 374-377. [10.1002/cbic.201600592]

Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding

Martini R.;Calcaterra A.;Iovine V.;Botta M.
2017

Abstract

In recent years many advances have been made in the fight against HIV-1 infection. However, the lack of a vaccine, together with the increasing resistance to the highly active anti-retroviral therapy (HAART), make HIV-1 infection still a serious global emergency. Thus, new compounds with original modes of action are continuously required, and natural products have ever been a very interesting class of pharmacologically active molecules. Some of them have been used since ancient times against viral infections. Here we present a work in which we suggest that kuwanon-L, a natural product active as an HIV-1 integrase (IN) inhibitor, might exert its overall antiviral activity through binding to multiple viral targets. Specific enzymatic tests, together with a time-of-addition (TOA) experiment, support our hypothesis of binding both to IN and to reverse transcriptase (RT). Overall, this compound can be considered an attractive lead for the development of new classes of antiviral agents able to overcome the problem of resistance, due to its ability to exert its action by binding simultaneously to multiple viral targets.
antiviral agents; HIV-1 RNase H; inhibitors; kuwanon-L; multiple target binding
01 Pubblicazione su rivista::01a Articolo in rivista
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding / Martini, R.; Esposito, F.; Corona, A.; Ferrarese, R.; Ceresola, E. R.; Visconti, L.; Tintori, C.; Barbieri, A.; Calcaterra, A.; Iovine, V.; Canducci, F.; Tramontano, E.; Botta, M.. - In: CHEMBIOCHEM. - ISSN 1439-4227. - 18:4(2017), pp. 374-377. [10.1002/cbic.201600592]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1641310
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
social impact